Isoniazid + pyrazinamide + rifampicin
Pharmaceutical forms
Tablet
Country lists
ATC N/A
Composition 75 mg + 400 mg + 150 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.2.4. Antituberculosis medicines
  • No observations
PAHO Strategic Fund Medicine List
2.3. Antituberculosis med.
  • No observations
Tablet
Country lists
ATC N/A
Composition 150 mg + 500 mg + 150 mg
Observations for this pharmaceutical form can be found on the lists:
WHO Model List of Essential Medicines
6.2.4. Antituberculosis medicines
  • Others observations:
    For intermittent use three times weekly.
PAHO Strategic Fund Medicine List
2.3. Antituberculosis med.
  • Others observations:
    Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times.